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Synthesis	of	substituted	tetrahydroisoquinolines	by	lithiation	then	
electrophilic	quench		
Ruaa	A.	Talk,	Alexia	Duperray,	Xiabing	Li,	and	Iain	Coldham*
	
Substituted	N-tert-butoxycarbonyl	(Boc)-1,2,3,4-tetrahydroisoquinolines	were	prepared	and	treated	with	n-butyllithium	in	
THF	at	–50	°C	to	test	the	scope	of	the	metallation	and	electrophilic	quench.	The	lithiation	was	optimised	by	using	in	situ	
ReactIR	spectroscopy	and	the	rate	of	rotation	of	the	carbamate	was	determined.	The	1-lithiated	intermediates	could	be	
trapped	with	a	variety	of	electrophiles	to	give	good	yields	of	1-substituted	tetrahydroisoquinoline	products.	Treatment	
with	acid	or	reduction	with	LiAlH4	allows	conversion	to	the	N–H	or	N–Me	compound.	The	chemistry	was	applied	to	the	
efficient	total	syntheses	of	the	alkaloids	(±)-crispine	A	and	(±)-dysoxyline.	
Introduction	
The	tetrahydroisoquinoline	ring	structure	 is	present	 in	a	 large	
number	of	natural	and	biologically	active	products.	Derivatives	
with	 a	 substituent	 in	 the	 1-position	 are	 particularly	 common	
and	 are	 typically	 prepared	 by	 Pictet–Spengler	 or	 Bischler–
Napieralksi	 reactions.
1
	 Other	 methods	 include	 addition	 to	
iminium	ions	or	reduction	of	isoquinoline	rings.
2
	An	alternative	
approach	 to	 such	 compounds	 makes	 use	 of	 the	 ability	 to	
deprotonate	 at	 the	 1-position	 of	 the	 tetrahydroisoquinoline	
ring.	 This	 method	 has	 potential	 to	 provide	 access	 to	 a	 large	
range	 of	 differently	 substituted	 derivatives.	 Various	 N-
substituents	on	the	tetrahydroisoquinoline	can	be	used	to	aid	
the	 metallation.
3
	 We	 have	 reported	 that	 an	 efficient	 and	
relatively	 mild	 method	 is	 to	 use	 the	 N-Boc	 derivative	 with	
deprotonation	 by	 using	 n-BuLi.
4,5
	 However	 we	 have	 so	 far	
reported	 only	 a	 few	 examples	with	 the	 parent	 compound	N-
Boc-tetrahydroisoquinoline	 1	 and	 with	 the	 6,7-dimethoxy	
derivative	2	(Fig.	1).
4
	Here	we	demonstrate	that	the	chemistry	
is	 amenable	 to	other	 substituted	 tetrahydroisoquinolines	and	
to	a	variety	of	different	electrophiles,	leading	to	its	application	
to	 the	 syntheses	 of	 the	 alkaloids	 (±)-crispine	 A	 and	 (±)-
dysoxyline.	
	 In	our	earlier	work	we	showed	that	the	Boc	group	in	N-Boc-
tetrahydroisoquinoline	 rotates	 slowly	 at	 –78	 °C.
4
	 As	 the	
lithiation	at	 the	1-position	 is	directed	by	 complexation	of	 the	
base	 (n-butyllithium)	 with	 the	 carbonyl	 of	 the	 Boc	 group,
6
	
better	yields	can	be	obtained	at	–50	°C	since	the	Boc	rotation	
is	 faster.	We	wanted	 to	 test	whether	 the	 same	phenomenon	
also	occurs	with	other	derivatives	and	whether	the	lithiation–
substitution	 chemistry	 is	 amenable	 to	 different	 substituted	
tetrahydroisoquinolines.	The	lithiations	of	a	selection	of	N-Boc-
tetrahydroisoquinoline	 compounds	 (2–5)	 and	 applications	 of	
this	chemistry	to	the	preparation	of	some	natural	products	are	
described	in	this	article.	
 
Fig.	1	 Structures	of	some	N-Boc-tetrahydroisoquinolines.	
Results	and	discussion	
We	 selected	 to	 prepare	 the	 tetrahydroisoquinolines	2–5	 (Fig.	
1).	 These	 compounds	 provide	 a	 range	 of	 electron-donating	
(alkoxy)	and	electron-withdrawing	(chloro	and	trifluoromethyl)	
groups	 on	 the	 tetrahydroisoquinolines	 used	 for	 the	 lithiation	
chemistry.	 For	 syntheses	 of	 compounds	 2–5,	 see	 the	
Supplementary	Information.		
	 The	 lithiation	 of	 tetrahydroisoquinoline	 3	 was	 monitored	
by	in	situ	ReactIR	spectroscopy.	With	1.2	equivalents	of	n-BuLi	
in	 THF	 at	 –78	 °C	 the	 lithiation	 was	 slow.	 However,	 by	
conducting	the	reaction	at	–50	°C	a	rapid	lithiation	took	place	
(Figure	 2).	 This	 result	 indicates	 that	 the	 rotation	 of	 the	 Boc	
group	is	slow	at	–78	°C,	but	fast	at	–50	°C,	in	line	with	previous	
work.
4,7
	The	n-BuLi	coordinates	to	the	carbonyl	oxygen	atom	of	
the	Boc	 group	 (sometimes	 referred	 to	 as	 a	 'complex	 induced	
proximity	 effect'),
6
	 so	 for	 benzylic	 lithiation	 to	 occur	 in	 high	
yield	 the	 Boc	 group	must	 rotate	 under	 the	 conditions	 of	 the	
reaction.		
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Fig.	2	 In	situ	IR	plot	of	the	lithiation	of	3	with	n-BuLi	in	THF	at	–50	°C	with	time	
in	h:min:sec.	νc=o	3	1696	cm
–1
,	n-BuLi	added	at	time	18	min,	νc=o	lithiated	3	1636	
cm
–1
.	
 
Scheme	1	 Lithiation–substitution	of	the	tetrahydroisoquinoline	3.	
	 By	using	the	optimised	lithiation	conditions	(THF,	–50	°C,	4	
min),	 followed	 by	 electrophilic	 quench	 and	 purification	 by	
column	 chromatography,	 the	 substituted	products	6a–c	were	
obtained	with	reasonable	to	good	yields	(Scheme	1).	Lithiation	
occurs	 only	 in	 the	 benzylic	 position,	 as	 judged	 by	
1
H	 NMR	
spectroscopy.	 We	 did	 not	 observe	 any	 other	 substitution	
products.		
	 To	 expand	 the	 range	 of	 substrates	 beyond	 the	 parent	 or	
electron-rich	 tetrahydroisoquinolines	 (compounds	 1–3),	 we	
prepared	 the	 tetrahydroisoquinolines	 4	 and	 5	 (see	 the	
Supplementary	Information).	We	found	that	these	compounds	
behaved	in	a	similar	way	and	lithiation	could	be	achieved	at	–
50	°C	over	the	course	of	only	a	few	minutes.	Some	examples	of	
the	substitution	products	that	were	obtained	in	this	chemistry	
are	 shown	 in	Schemes	2	and	3.	The	chemistry	was	 successful	
for	a	variety	of	electrophiles	including	alkyl	and	allyl	bromides,	
and	trialkyltin	or	silyl	chlorides.	After	column	chromatography	
reasonable	 to	good	yields	of	 the	1-substituted	products	7a–d	
and	 8a–c	 were	 obtained.	 The	 lithiation–substitution	 was	
selective	 for	 the	1-position,	 indicating	 that	 the	Boc	group	 is	a	
better	directing	group	for	lithiation	than	CF3	or	chlorine.			
	 As	 mentioned	 above,	 in	 the	 lithiation	 step	 the	 n-BuLi	
coordinates	 to	 the	 carbonyl	 oxygen	 atom,
6
	 so	 the	 rate	 of	
lithiation	will	depend	on	the	rate	of	rotation	of	the	Boc	group.	
We	 had	 previously	 determined	 an	 approximate	 value	 for	 the	
barrier	to	rotation,	ΔG
‡
	≈	60.8	kJmol
–1
	at	5.5	°C	of	the	parent	
compound	1.
4
	We	therefore	decided	to	determine	the	kinetics	
for	rotation	of	the	Boc	group	for	the	tetrahydroisoquinoline	4	
for	 comparison.	 Variable	 temperature	 NMR	 spectroscopy	 in	
D8-THF	 was	 carried	 out	 and	 coalescence	 of	 the	 benzylic	 CH2	
signals	occurred	at	about	5	°C	(for	selected	spectra,	see	Fig.	3).	
Line	shape	analysis	(see	SI)	revealed	activation	parameters	ΔH
‡
	
≈	 81	 kJmol
–1
	 and	ΔS
‡
	≈	 77	 JK
–1
mol
–1
.	 These	 values	 lead	 to	 a	
similar	overall	barrier	to	rotation	(ΔG
‡
	≈	60	kJmol
–1
	at	5	°C)	for	
the	Boc	group	 in	both	compounds	4	 and	1.	 From	this	we	can	
determine,	for	rotation	of	the	Boc	group	in	4,	the	half-life	t1/2	≈	
2	min	 at	 –50	 °C.	 Therefore	 the	 lithiation	 requires	 only	 a	 few	
minutes	at	this	temperature	for	complete	reaction.		
	 By	 using	 1.2	 equivalents	 of	 the	 electrophile	 1,3-
dibromopropane,	 the	 1-substituted	 product	 7d	 was	 formed	
without	any	appreciable	formation	of	the	product	from	double	
electrophilic	 substitution.	 The	 product	 7d	 was	 treated	 with	
trifluoroacetic	 acid	 (TFA)	 (Scheme	 4).	 This	 resulted	 in	 the	
removal	of	 the	Boc	group	and	concomitant	cyclization	to	give	
the	product	9	in	high	yield.		
 
Scheme	2	 Lithiation–substitution	of	the	tetrahydroisoquinoline	4.	
 
Scheme	3	 Lithiation–substitution	of	the	tetrahydroisoquinoline	5.	
add n-BuLi
N
Boc
3
N
Boc
6aÐc
E
THF, Ð50 ¡C, 4 min
then
1.2 equiv. n-BuLi
N
Boc
6b 66%
E+ = PhCH2Br
electrophile (E+)
O
O
O
O
O
O
N
Boc
Me
O
O
6a 82%
E+ = MeI
N
Boc
6c
SiMe3
72%
E+ = TMSCl
O
O
Ph
THF, Ð50 ¡C, 4 min
then
1.2 equiv. n-BuLi
N
Boc
7b 61%
E+ = PhCH2CH2CH2Br
electrophile (E+)
N
Boc
7a 60%
E+ = n-BuBr
N
Boc
4
CF3
N
Boc
7
CF3
E
CF3 CF3
Ph
N
Boc
7d 68%
E+ = BrCH2CH2CH2Br
N
Boc
7c 64%
E+ = PhOCH2CH2CH2Br
CF3 CF3
OPh Br
THF, Ð50 ¡C, 4 min
then
1.2 equiv. n-BuLi
N
Boc
8b
SiMe3
68%
E+ = TMSCl
electrophile (E+)
N
Boc
8a 91%
E+ = allyl bromide
N
Boc
SnBu3
8c 57%
E+ = n-Bu3SnCl
N
BocCl
5
N
BocCl
8 E
Cl
Cl
Cl
Journal	Name	 	ARTICLE	
This	journal	is	©	The	Royal	Society	of	Chemistry	20xx	 J.	Name.,	2013,	00,	1-3	|	3 	
Please	do	not	adjust	margins	
Please	do	not	adjust	margins	
 
Fig.	3	 Variable	temperature	NMR	spectroscopy	of	tetrahydroisoquinoline	4	in	
D8-THF	showing	selected	spectra	only	the	region	from	5.00–3.50	ppm.	
 
Scheme	4	 Removal	of	Boc	group	from	the	tetrahydroisoquinoline	7d.	
	 We	 were	 interested	 to	 test	 dibromoalkane	 electrophiles	
further	 and	 selected	 to	 use	 the	 tetrahydroisoquinoline	
substrate	2	for	this	work.	Lithiation	of	compound	2	with	n-BuLi	
in	THF	at	–50	°C	for	4	min	followed	by	addition	of	more	than	
one	equivalent	of	1,3-dibromopropane	or	1,4-dibromobutane	
gave	the	expected	1-substituted	products	10	and	11	 (Scheme	
5).	 By	 using	 0.5	 equivalents	 of	 1,3-dibromopropane	we	were	
able	 to	 prepare	 the	 1,1'-disubstituted	 product	 14	 as	 a	
separable	 mixture	 of	 diastereoisomers.	 Related	 bis-
tetrahydroisoquinolinium	salts	have	recently	been	found	to	be	
high	affinity	ligands	for	SK	channels.
8
			
 
Scheme	5	 Use	of	dibromoalkane	electrophiles	and	synthesis	of	(±)-crispine	A.	
	 Treatment	of	the	crude	product	10	with	trifluoroacetic	acid	
gave	 the	natural	product	 (±)-crispine	A,	12,	 in	52%	yield	over	
the	 two	 steps.	 This	 chemistry	 therefore	 provides	 a	 short	 and	
efficient	 synthesis	 of	 this	 compound	 (just	 three	 steps	 from	
commercial	 6,7-dimethoxytetrahydroisoquinoline).
9
	 In	 the	
same	way	as	the	formation	of	crispine	A,	hydrolysis	of	the	Boc	
group	 from	 compound	 11	 was	 carried	 out	 to	 provide	 the	
homologous	product	13	in	high	yield	(Scheme	5).
10
		
	 To	expand	the	range	of	electrophiles	that	have	been	shown	
to	be	 successful	 in	 these	 alkylation	 reactions,	we	 treated	 the	
tetrahydroisoquinoline	2	with	n-BuLi	in	THF	at	–50	°C	for	4	min	
followed	by	addition	of	propargyl	bromide	or	4-methoxybenzyl	
chloride	 (Scheme	 6).	 The	 products	 15	 and	 16	 were	 isolated	
with	good	yields.		
	 We	have	demonstrated	that	the	Boc	group	can	be	removed	
from	several	of	these	products	(7d,	10,	11)	by	using	TFA.	Other	
transformations	 of	 the	 substituted	 products	 are	 possible.	 For	
example,	 treating	 the	 product	 15	 with	 benzyl	 azide	 and	 a	
copper	 catalyst	 gave	 the	 expected	 triazole	 17	 (Scheme	 7).
11
	
Reduction	 of	 the	 Boc	 group	 in	 the	 tetrahydroisoquinoline	 6b	
with	LiAlH4	gave	the	N-methyl	derivative	18	(Scheme	8).		
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Scheme	6	 Lithiation–substitution	of	the	tetrahydroisoquinoline	2.	
 
Scheme	7	 Further	transformation	of	the	product	16.	
 
Scheme	8	 Reduction	of	the	tetrahydroisoquinoline	6b.	
	 Finally,	 we	 prepared	 the	 natural	 product	 (±)-dysoxyline	
using	 this	 chemistry.
12
	 The	 tetrahydroisoquinoline	 2	 was	
deprotonated	under	the	standard	conditions	and	then	treated	
with	 the	 bromide	 19	 (Scheme	 9).	We	were	 pleased	 that	 this	
gave	a	good	yield	of	the	1-substituted	product	20	despite	the	
potential	 for	 β-elimination.	 Reduction	 of	 this	 product	 with	
LiAlH4	 gave	 (±)-dysoxyline	21.	Hence	 this	 chemistry	 allows	 an	
efficient	 way	 to	 prepare	 simple	 tetrahydroisoquinoline	
alkaloids.	
 
Scheme	9	 Synthesis	of	(±)-dysoxyline.	
Conclusions	
	 We	 have	 found	 that	 the	 lithiation	 of	 N-Boc-
tetrahydroisoquinolines	 can	 be	 extended	 to	 a	 selection	 of	
different	substituted	derivatives	by	using	the	conditions	found	
previously	for	the	parent	compound	(1)	and	this	requires	only	
a	few	minutes	at	–50	°C	with	n-butyllithium.	The	intermediate	
organolithium	 can	 be	 trapped	 with	 a	 wide	 selection	 of	
different	 electrophiles	 to	 give	 good	 yields	 of	 a	 variety	 of	 1-
substituted	 tetrahydroisoquinoline	 products.	 The	 chemistry	
was	applied	 to	 the	short	syntheses	of	 the	alkaloids	crispine	A	
and	dysoxyline.		
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Experimental	
tert-Butyl	 7,8-Dihydro-5-Methyl-[1,3]dioxolo[4,5-
g]isoquinoline-6(5H)-carboxylate	6a	
n-BuLi	 (0.17	mL,	 0.43	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	3	(100	mg,	0.36	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	iodomethane	(0.08	mL,	1.26	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(92:8),	to	give	the	carbamate	6a	(85	mg,	82%)	as	plates;	
m.p.	81-82	°C;	Rƒ	0.39	[petrol–EtOAc	(90:10)];	νmax	(neat)/cm
–1
	
2970,	2875,	1670,	1485;	
1
H	NMR		(400	MHz,	CDCl3,	rotamers)	δ	
=	6.58–6.57	(2H,	m,	2	x	CH),	5.80	(2H,	s,	CH2),	5.18–4.96	(1H,	br	
m,	CH),	4.27–3.91	(1H,	br	m,	CH),	3.67–2.60	(3H,	br	m,	3	x	CH),	
1.50	 (9H,	 s,	 t-Bu),	 1.40	 (3H,	 d,	 J	 7,	 CH3);	
13
C	NMR	 (100	MHz,	
CDCl3,	rotamers)	δ	=	154.9	&	154.4,	146.1,	146.0,	127.3,	127.1,	
108.4,	106.7,	100.7,	79.6,	50.5	&	49.8,	38.0	&	36.6,	29.6,	29.0	
&	28.0,	22.0;	HRMS	(ES)	Found:	MNa
+
,	314.1360.	C16H22NO4Na	
requires	MNa
+
,	314.1368;	LRMS	m/z	(ES)	314	(100%).	
	
tert-Butyl	 5-Benzyl-7,8-dihydro-[1,3]dioxolo[4,5-
g]isoquinoline-6(5H)-carboxylate		6b	
n-BuLi	 (0.17	mL,	 0.43	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	3	(100	mg,	0.36	mmol)	in	THF	(1.5	mL)	
at	 –50	 °C.	After	 4	min,	 benzyl	 bromide	 (0.15	mL,	 1.26	mmol)	
was	 added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(93:7),	to	give	the	carbamate	6b	(87	mg,	66%)	as	an	oil;	
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Rƒ	 0.41	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	 2975,	 2925,	
1680,	1485;	
1
H	NMR	(400	MHz,	CDCl3)	δ	=	7.36–7.20	(3H,	m,	3	
x	 CH),	 7.15–7.04	 (2H,	m,	 2	 x	 CH),	 6.61–6.54	 (2H,	m,	 2	 x	 CH),	
5.94–5.90	 (2H,	 m,	 CH2),	 5.27	 (0.35H,	 t,	 J	 7,	 CH),	 5.13–5.10	
(0.65H,	m,	CH),	4.20–4.12	(0.65H,	m,	CH),	3.81–3.72	(0.35H,	m,	
CH),	 3.34–3.23	 (1H,	m,	 CH),	 3.06–2.95	 (2H,	m,	 CH),	 2.91-2.81	
(0.65H,	m,	CH),	2.74–2.67	(0.35H,	m,	CH),	2.63–2.57	(0.65H,	m,	
CH),	2.52–2.46	(0.35H,	m,	CH),	1.26	(9H,	s,	t-Bu);	
13
C	NMR	(100	
MHz,	CDCl3,	rotamers)	δ=	154.5	&	154.3,	146.3	&	146.1,	145.8	
&	145.7,	138.5	&	138.1,	130.1	&	130.0,	129.7	&	129.6,	129.0	&	
128.8,	 128.3,	 128.1,	 127.8	 &	 127.7,	 126.4	 &	 126.2,	 108.6	 &	
108.2,	107.6	&	107.2,	100.8	&	100.7,	79.6	&	79.4,	56.8	&	55.7,	
43.0	&	42.7,	39.3	&	37.0,	29.7	&	28.6,	28.5	&	28.4;	HRMS	(ES)	
Found:	 MNa
+
,	 390.1674.	 C22H26NO4Na	 requires	 MNa
+
	
390.1618,	LRMS	m/z	(ES)	390	(100%).	
	
tert-Butyl	 7,8-Dihydro-5-(trimethylsilyl)-[1,3]dioxolo[4,5-
g]isoquinoline-6(5H)-carboxylate	6c	
n-BuLi	 (0.17	mL,	 0.43	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	3	(100	mg,	0.36	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	Me3SiCl	(0.16	mL,	1.2	mmol)	was	added.	
The	mixture	was	allowed	to	warm	to	 room	temperature	over	
16	h	and	MeOH	(1	mL)	was	added.	The	solvent	was	evaporated	
and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (92:8),	 to	 give	 the	
carbamate	 6c	 (90	 mg,	 72%)	 as	 an	 oil;	 Rƒ	 0.36	 [petrol–EtOAc	
(90:10)];	 νmax	 (neat)/cm
–1	
2965,	 2930,	 1680,	 1480,	 836,	
1
H	
NMR	 (400	MHz,	 CDCl3,	 rotamers)	 δ	 =	 6.60	 (0.5H,	 s,	 CH),	 6.57	
(0.5H,	 s,	CH),	6.46	 (0.5H,	 s,	 CH),	6.45	 (0.5H,	 s,	CH),	5.92–5.89	
(2H,	m,	CH),	4.83	(0.5H,	br,	CH),	4.67	(0.5H,	br,	CH),	4.18	(0.5H,	
dt,	 J	12,	5,	CH),	3.93	 (0.5H,	dt,	J	12,	5,	CH),	3.25	 (0.5H,	ddd,	 J	
12,	9,	5,	CH),	3.11–3.05	(0.5H,	m,	CH),	2.90–2.78	(1H,	m,	CH),	
2.65–2.55	(1H,	m,	CH),	1.50	(4.5H,	s,	t-Bu),	1.49	(4.5H,	s,	t-Bu),	
0.06	(4.5H,	s,	SiMe3),	0.05	(4.5H,	s,	SiMe3);	
13
C	NMR	(100	MHz,	
CDCl3,	rotamers)	δ=	154.4,	145.9	&	144.8,	145.1	&	144.9,	130.3	
&	129.7,	125.7	&	125.6,	108.9	&	108.6,	105.4	&	105.1,	100.7	&	
100.6,	 79.7	 &	 79.2,	 49.9	 &	 49.0,	 41.0	 &	 39.8,	 28.9	 &	 28.55,	
28.5,	 –1.4	 &	 –1.6;	 HRMS	 (ES)	 Found:	 MNa
+
,	 372.1603.	
C18H28NO4SiNa	 requires	 MNa
+
	 372.1607;	 LRMS	m/z	 (ES)	 372	
(100%).	
	
tert-Butyl	 1-Butyl-5-(trifluoromethyl)-1,2,3,4-
tetrahydroisoquinoline-2-carboxylate	7a	
n-BuLi	 (0.19	mL,	 0.49	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	4	(100	mg,	0.33	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	n-butyl	bromide	 (0.12	mL,	1.16	mmol)	
was	 added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(98:2),	to	give	the	carbamate	7a	(70	mg,	60%)	as	an	oil;	
Rƒ	 0.36	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	 2965,	 2930,	
1690,	1425;	
1
H	NMR		(400	MHz,	CDCl3,	rotamers)	δ	=	7.52–7.51	
(1H,	m,	CH),	7.29–7.28	(2H,	m,	2	x	CH),	5.21–5.18	(0.5H,	br	m,	
CH),	 5.07–5.05	 (0.5H,	 br	m,	 CH),	 4.25–4.22	 (0.5H,	 br	m,	 CH),	
4.00–3.97	 (0.5H,	 br	 m,	 CH),	 3.36–3.15	 (1H,	 br	 m,	 CH),	 3.05–
2.93	(2H,	br	m,	2	x	CH),	1.89–1.66	(2H,	br	m,	CH),	1.50	(9H,	s,	t-
Bu),	 1.45–1.29	 (4H,	 m,	 4	 x	 CH),	 0.94–0.89	 (3H,	 m,	 CH3);	
13
C	
NMR	 (100	 MHz,	 CDCl3,	 rotamers)	 δ	 =	 154.8,	 140.3	 &	 140.1,	
133.3	 &	 133.0,	 131.2	 &	 130.9,	 128.3	 (q,	 J	 28.5	 Hz),	 125.6,	
124.1,	121.7	 (CF3,	 q,	 J	269),	80.0	&	79.7,	54.9	&	54.1,	37.7	&	
36.9,	 36.5	&	35.9,	 29.7	&	28.7,	 28.4,	 25.2	&	25.1,	 22.5,	 14.0;	
HRMS	 (ES)	 Found:	 MNa
+
,	 380.1795.	 C19H26NO2F3Na,	 requires	
MNa
+
	380.1813;	LRMS	m/z	(ES)	380	(100%).	
	
tert-Butyl	 5-(Trifluoromethyl)-3,4-dihydro-1-(3-
phenylpropyl)isoquinoline-2(1H)-carboxylate	7b	
n-BuLi	 (0.19	mL,	 0.49	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	4	(100	mg,	0.33	mmol)	in	THF	(1.5	mL)	
at	 –50	 °C.	 After	 4	min,	 Br(CH2)3Ph	 (0.17	mL,	 1.16	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	7b	(84	mg,	61%)	as	an	oil;	
Rƒ	 0.25	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	 2970,	 2930,	
1690,	1420;	
1
H	NMR		(400	MHz,	CDCl3,	rotamers)	δ	=	7.53–7.52	
(1H,	 m,	 CH),	 7.30–7.19	 (7H,	 m,	 7	 x	 CH),	 5.30–5.25	 (0.5H,	 m,	
CH),	 5.09–5.00	 (0.5H,	m,	 CH),	 4.30–4.16	 (0.5H,	m,	 CH),	 4.00–
3.97	(0.5H,	m,	CH),	3.26–3.16	(1H.	m,	CH),	3.05–2.92	(2H,	m,	2	
x	 CH),	 2.75–2.67	 (2H,	m,	 2	 x	 CH),	 1.90–1.72	 (4H,	m,	 4	 x	 CH),	
1.51	 (4.5H,	 s,	 t-Bu),	 1.49	 (4.5H,	 s,	 t-Bu);	
13
C	 NMR	 (100	MHz,	
CDCl3,	 rotamers)	 δ	 =	 154.8	 &	 154.6,	 142.2	 &	 141.8,	 140.1	 &	
139.8,	133.3	&	133.0,	131.2,	130.9,	128.3,	125.8,	124.3	(CF3,	q,	
J	270),	124.2,	80.1	&	79.8,	54.9	&	53.8,	37.6,	36.4,	36.0,	35.4,	
28.4,	 27.9,	 25.2	 &	 25.1;	 HRMS	 (ES)	 Found:	 MNa
+
,	 442.1961.	
C24H28NO2F3Na	 requires	 MNa
+
	 442.1970;	 LRMS	m/z	 (ES)	 442	
(100%).	
	
tert-Butyl	 5-(Trifluoromethyl)-3,4-dihydro-1-(3-
phenoxypropyl)isoquinoline-2(1H)-carboxylate	7c	
n-BuLi	 (0.19	mL,	 0.49	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	4	(100	mg,	0.33	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	Br(CH2)3OPh	(0.17	mL,	1.16	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	7c	(90	mg,	64%)	as	an	oil;	
Rƒ	 0.22	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	 2970,	 1685,	
1420;	
1
H	NMR	 	 (400	MHz,	 CDCl3)	 δ	 =	 7.52–7.45	 (1H,	m,	 CH),	
7.37–7.25	(4H,	m,	4	x	CH),	6.96–6.90	(3H,	m,	3	x	CH),	5.30–5.27	
(0.5H,	 m,	 CH),	 5.15–5.12	 (0.5H,	 m,	 CH),	 4.30–4.25	 (0.5H,	 m,	
CH),	4.10–4.02	(2.5H,	m,	CH),	3.37–3.20	(1H,	m,	CH),	3.08–2.98	
(2H,	m,	2	x	CH),	2.03–1.90	 (4H,	m,	4	x	CH),	1.50	 (9H,	s,	t-Bu);	
13
C	NMR	(100	MHz,	CDCl3,	rotamers)	δ	=	159.0,	154.9	&	154.5,	
140.2	&	139.7,	133.3	&	133.0	(C),	131.2	&	130.9,	129.4,	128.6	
(q,	 J	 31),	 125.8,	 124.3,	 121.0	 (CF3,	 q,	 J	 274),	 120.7	 &	 120.6,	
114.5,	80.2	&	79.9,	67.2,	54.6	&	53.7,	37.6	&	36.0,	33.5	&	33.1,	
29.7	 &	 28.4,	 26.2,	 25.2	 &	 25.0;	 HRMS	 (ES)	 Found:	 MNa
+
,	
458.1918.	C24H29NO3F3Na	requires	MNa
+
,	458.1919;	LRMS	m/z	
(ES)	458	(100%).	
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tert-Butyl	 1-(3-Bromopropyl)-5-(trifluoromethyl)-1,2,3,4-
tetrahydroisoquinoline-2-carboxylate	7d	
n-BuLi	 (0.31	mL,	 0.78	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	4	(200	mg,	0.66	mmol)	in	THF	(3	mL)	at	
–50	 °C.	 After	 4	 min,	 Br(CH2)3Br	 (0.08	 mL,	 0.79	 mmol)	 was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	7d	(180	mg,	68%)	as	an	oil;	
Rƒ	 0.4	 [petrol–EtOAc	 (80:20)];	 νmax	 (neat)/cm
–1
	 2975,	 2925,	
1690,	1420;	
1
H	NMR		(400	MHz,	CDCl3,	rotamers)	δ	=	7.55–7.53	
(1H,	 m,	 CH),	 7.35–7.30	 (2H,	 m,	 2	 x	 CH),	 5.26–5.23	 (0.5H,	 m,	
CH),	 5.10–5.08	 (0.5H,	m,	 CH),	 4.33–4.27	 (0.5H,	m,	 CH),	 4.08–
4.06	 (0.5H,	m,	CH),	3.68–3.51	 (2H,	m,	2	x	CH),	3.31–3.15	 (1H,	
m,	CH),	3.00–2.97	(2H,	m,	2	x	CH),	2.05–1.95	(4H,	m,	4	x	CH),	
1.50	 (9H,	 s,	 t-Bu);	
13
C	 NMR	 (100	 MHz,	 CDCl3,	 rotamers)	 δ	 =	
154.9	 &	 154.2,	 139.7,	 139.2,	 133.6	 &	 132.6,	 131.3	 &	 130.8,	
125.9	&	125.8,	124.4,	124.3	(q,	J	280),	80.5	&	80.0,	54.1	&	52.9,	
37.6	&	35.9,	35.2	&	34.7,	33.5	&	33.0,	29.8	&	29.2,	28.4,	25.6	&	
25.0;	 HRMS	 (ES)	 Found:	 MNa
+
,	 444.0754.	 C18H23NO2F3
79
BrNa	
requires	 MNa
+	
444.0762;	 LRMS	 m/z	 (ES)	 446	 (97%),	 444	
(100%).	
	
tert-Butyl	 1-Allyl-7-chloro-3,4-dihydroisoquinoline-2(1H)-
carboxylate	8a	
n-BuLi	 (0.17	mL,	 0.44	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	5	(100	mg,	0.37	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	allyl	bromide	(0.13	mL,	1.3	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(98:2),	to	give	the	carbamate	8a	(100	mg,	91%)	as	plates	
m.p.	 94–96	 °C;	 Rƒ	 0.6	 [petrol–EtOAc	 (95:5)];	 νmax	 (neat)/cm
–1
	
2975,	2930,	1690,	1420;	
1
H	NMR	(400	MHz,	CDCl3,	rotamers)	δ	
=	7.15–7.14	(2H,	m,	2	x	CH),	7.08–7.06	(1H,	m,	CH),	5.85–5.80	
(1H,	m,	CH),	5.26–5.24	(0.4H,	m,	CH),	5.10–5.06	(2.6H,	m,	CH),	
4.25–4.22	 (0.6H,	 m,	 CH),	 4.01–3.96	 (0.4H,	 m,	 CH),	 3.30–3.13	
(1H,	 m,	 CH),	 2.93–2.85	 (1H,	 m,	 CH),	 2.73–2.70	 (1H,	 m,	 CH),	
2.56–2.52	 (2H,	 m,	 2	 x	 CH),	 1.50	 (9H,	 s,	 t-Bu);	
13
C	 NMR	 (100	
MHz,	CDCl3,	rotamers)	δ	=	154.7	&	154.5,	139.1	&	138.9,	134.6,	
132.9	 &	 132.7,	 131.5,	 130.4	 &	 130.0,	 127.1,	 126.8	 &	 126.7,	
117.7	&	117.3,	80.1	&	79.7,	54.2	&	53.3,	41.3	&	41.0,	38.2	&	
36.5,	 28.4,	 28.2	 &	 28.0;	 HRMS	 (ES)	 Found:	 MNa
+
,	 330.1223.	
C17H22
35
ClNO2	 requires	 MNa
+
	 330.1237;	 LRMS	 m/z	 (ES)	 332	
(33%),	330	(100%).	
	
tert-Butyl	 7-Chloro-3,4-dihydro-1-(trimethylsilyl)isoquinoline-
2(1H)-carboxylate	8b	
n-BuLi	 (0.17	mL,	 0.44	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	5	(100	mg,	0.37	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	Me3SiCl	(0.13	mL,	1.0	mmol)	was	added.	
The	mixture	was	allowed	to	warm	to	 room	temperature	over	
16	h	and	MeOH	(1	mL)	was	added.	The	solvent	was	evaporated	
and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (98:2),	 to	 give	 the	
carbamate	8b	(85	mg,	68%)	as	plates,	m.p.	115–116	°C;	Rƒ	0.36	
[petrol–EtOAc	 (95:5)];	 νmax	 (neat)/cm
–1
	 2980,	 2930,	 1700,	
1420,	935;	
1
H	NMR		(400	MHz,	CDCl3,	rotamers)	δ	=	7.05–7.03	
(2H,	m,	2	x	CH),	6.96–6.95	(1H,	m,	CH),	4.95	(0.5H,	s,	CH),	4.78	
(0.5H,	s,	CH),	4.30–4.20	 (0.5H,	m,	CH),	4.00	 (0.5H,	dt,	12.5,	5,	
CH),	3.25	(0.5H,	ddd,	J	12.5,	9,	5,	CH),	3.10–3.05	(0.5H,	m,	CH),	
2.95–2.82	(1H,	m,	CH),	2.72–2.65	(1H,	m,	CH),	1.50	(4.5H,	s,	t-
Bu),	1.48	(4.5H,	s,		t-Bu),	0.09–0.06	(9H,	m,	CH3);	
13
C	NMR	(100	
MHz,	CDCl3,	rotamers)	δ	=	154.4	&	154.3,	139.2	&	138.7,	131.4	
&	131.3,	131.2	&	131.1,	130.8	&	130.4,	129.9	&	128.8,	125.0	&	
124.6,	79.9	&	79.4,	49.7	&	48.9,	40.8	&	39.5,	28.5	&	28.4,	28.3	
&	 28.0,	 -1.4	 &	 -1.7;	 HRMS	 (ES)	 Found:	 MNa
+
,	 362.1329.	
C17H26NO2NaSi
35
Cl	 requires	M
+
	 362.1319;	 LRMS	m/z	 (ES)	 364	
(33%),	362	(100).	
	
tert-Butyl	 1-(Tributylstannyl)-7-chloro-3,4-
dihydroisoquinoline-2(1H)-carboxylate	8c	
n-BuLi	 (0.17	mL,	 0.44	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	5	(100	mg,	0.37	mmol)	in	THF	(1.5	mL)	
at	 –50	 °C.	 After	 4	 min,	 n-Bu3SnCl	 (0.36	 mL,	 1.3	 mmol)	 was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(95:5),	to	give	the	carbamate	8b	(120	mg,	57%)	as	an	oil;	
Rƒ	 0.6	 [petrol–EtOAc	 (95:5)];	 νmax	 (neat)/cm
–1
	 2955,	 2925,	
2855,	 1700,	 1150;	
1
H	 NMR	 	 (400	MHz,	 CDCl3,	 rotamers)	 δ	 =	
7.00–6.95	 (2H,	m,	 2	 x	 CH),	 6.85–6.80	 (1H,	m,	 CH),	 5.34–5.17	
(1H,	m,	 CH),	 4.35–4.25	 (0.5H,	m,	 CH),	 3.85	 (0.5H,	 dt,	 J	12,	 6,	
CH),	3.31	 (0.5H,	ddd,	 J	12,	8,	4,	CH),	3.01–2.85	 (1.5H,	m,	CH),	
2.75–2.65	(1H,	m,	CH),	1.60	(4.5H,	s,	t-Bu),	1.59	(4.5H,	s,	t-Bu),	
1.45–1.20	 [12H,	 m,	 Sn(CH2CH2CH2CH3)3],	 0.95–0.78	 [15H,	 m,	
Sn(CH2CH2CH2CH3)3];	
13
C	NMR	(100	MHz,	CDCl3,	 rotamers	and	
C=O	could	not	be	observed)	δ	=	131.8,	130.1	&	129.5,	130.0,	
129.9	&	129.8,	123.9	&	123.7,	123.4,	79.4,	49.6	&	49.3,	41.7	&	
40.6,	29.0,	28.9	&	28.8,	28.6	&	28.5,	27.4	&	27.3,	13.5,	10.6	&	
10.4;	 HRMS	 (ES)	 Found:	 MH
+
,	 558.2134.	 C26H45NO2
35
Cl
120
Sn,	
requires	MH
+
;	558.2161;	LRMS	m/z	(ES)	560	(33%),	558	(100%).	
	
7-(Trifluoromethyl)-1H,2H,3H,5H,6H,10bH-pyrrolo[2,1-
a]isoquinoline	9	
Trifluoroacetic	 acid	 (0.28	 mL,	 3.66	 mmol)	 was	 added	 to	 the	
tetrahydroisoquinoline	 7d	 (400	 mg,	 0.95	 mmol)	 in	 CH2Cl2	 (5	
mL)	at	room	temperature.	After	4	h,	the	solvent	was	removed	
under	 reduced	 pressure.	 Aqueous	 NaOH	 (30	 mL,	 1	 M)	 was	
added	and	the	mixture	was	extracted	with	CH2Cl2	(2	×	10	mL).	
The	 combined	 extracts	were	 dried	 (MgSO4),	 evaporated,	 and	
the	 residue	was	purified	by	 column	chromatography	on	 silica	
gel,	eluting	with	petrol–EtOAc	(92:8),	to	give	the	amine	9	(210	
mg,	 91%)	 as	 a	 solid;	 m.p.	 76–78	 °C;	 Rf	 0.5	 [petrol–EtOAc	
(80:20)];	 νmax	 (neat)/cm
–1
	 2920,	 2850,	 1470,	 1375;	
1
H	 NMR		
(400	MHz,	CDCl3,	 rotamers)	δ	=	7.52–7.50	 (1H,	m,	CH),	 7.29–
7.23	(2H,	m,	2	x	CH),	3.27–3.04	(4H,	m,	4	x	CH),	2.69–2.54	(2H,	
m,	2	x	H),	2.45–2.37	(1H,	m,	CH),	2.01–1.71	(4H,	m	4	x	CH);	
13
C	
NMR	 (100	 MHz,	 CDCl3,	 rotamers)	 δ=	 140.5,	 133.0,	 129.6,	
128.1,	(q,	J	25),	125.7,	124.5	(CF3,	q,	J	276),	123.9	(q,	J	7),	63.5,	
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53.5,	47.9,	30.6,	25.4,	22.1;	HRMS	(ES)	Found:	MH
+
,	242.1147.	
C13H15NF3	requires	MH
+	
242.1157;	LRMS	m/z	(ES)	242	(100%).	
	
tert-Butyl	 1-(4-Bromobutyl)-6,7-dimethoxy-1,2,3,4-
tetrahydroisoquinoline-2-carboxylate	11	
n-BuLi	 (1.24	mL,	 2.86	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	2	 (700	mg,	2.38	mmol)	 in	THF	(10	mL)	
at	 –50	 °C.	 After	 4	min,	 Br(CH2)4Br	 (0.34	mL,	 2.86	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(98:2),	to	give	the	carbamate	11	(760	mg,	75%)	as	an	oil;	
Rƒ	 	 0.21	 [petrol–EtOAc	 (80:20)];	νmax	 (neat)/cm
–1
	 2965,	 2935,	
1680,	 1515,	 1415;	
1
H	 NMR	 	 (400	MHz,	 CDCl3,	 rotamers)	 δ	 =	
6.61–6.60	(2H,	m,	2	x	CH),	5.12–5.08	(0.5H,	m,	CH),	4.98–4.95	
(0.5H,	m,	CH),	4.27–4.23	(0.5H,	m,	CH),	4.01–3.98	(0.5,	m,	CH),	
3.88	 (6H,	br	 s,	2	x	CH3),	3.48–3.42	 (2H,	m,	2	x	CH),	3.27–3.22	
(0.5H,	m,	CH),	3.15–3.08	(0.5H,	m,	CH),	3.00–2.79	(1H,	m,	CH),	
2.65–2.61	(1H,	m,	CH),	2.06–1.54	(6H,	m,	6	x	CH),	1.51	(9H,	br	
s,	t-Bu);	
13
C	NMR	(100	MHz,	CDCl3,	rotamers)	δ	=	154.8,	147.8,	
147.4,	 130.2	 &	 129.8,	 126.5	 &	 126.0,	 111.6,	 110.2	 &	 109.9,	
79.9	&	79.5,	56.1,	55.9,	54.2	&	53.4,	38.3	&	36.5,	36.2	&	35.7,	
33.6,	 32.5,	 28.4,	 27.9,	 25.4	&	 25.1;	 HRMS	 (ES)	 Found:	MNa
+
,	
450.1247.	 C20H30NO4
79
BrNa	 requires	 MNa
+	
450.1256;	 LRMS	
m/z	(ES)	452	(97%),	450	(100%).	
	
Crispine	A	12	
n-BuLi	 (1.63	 mL,	 4.1	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	2	(1.0	g,	3.4	mmol)	in	THF	(14	mL)	at	–
50	°C.	After	4	min,	dibromopropane	(0.41	mL,	4.1	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 to	 give	 the	 crude	 product	 10.	
Trifluoroacetic	 acid	 (0.37	 mL,	 4.9	 mmol)	 was	 added	 to	 this	
crude	product	10	in	CH2Cl2	(15	mL)	and	the	mixture	was	stirred	
at	 room	 temperature.	 After	 4	 h,	 the	 solvent	was	 evaporated	
and	aqueous	NaOH	(30	mL,	1	M)	was	added.	The	mixture	was	
extracted	with	CH2Cl2	(2	×	20	mL).	The	combined	extracts	were	
dried	 (MgSO4),	 evaporated,	 and	 purified	 by	 column	
chromatography	on	silica,	eluting	with	petrol–EtOAc	(92:8),	to	
give	 (±)-crispine	 A	 (410	 mg,	 52%)	 as	 an	 oil;	 Rf	 0.18	 [petrol–
EtOAc	(80:20)];	
1
H	NMR		(400	MHz,	CDCl3)	δ	=	6.63	(1H,	s,	CH),	
6.58	 (1H,	 s,	CH),	4.12–4.05	 (1H,	m,	CH),	3.86	 (6H,	 s,	2	x	CH3),	
3.21–3.17	(2H,	m,	2	x	CH),	3.12–3.05	(2H,	m,	2	x	CH),	2.97–2.96	
(2H,	m,	2	x	CH),	2.56–2.48	(1H,	m,	CH),	2.07–1.99	(2H,	m,	2	x	
CH),	1.93–1.83	(1H,	m,	CH).	Data	as	reported.
9	
	
9,10-Dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-
a]isoquinoline	13	
Trifluoroacetic	 acid	 (0.1	 mL,	 1.48	 mmol)	 was	 added	 to	 the	
tetrahydroisoquinoline	 11	 (100	 mg,	 0.24	 mmol)	 in	 CH2Cl2	 (5	
mL)	and	the	mixture	was	stirred	at	room	temperature.	After	4	
h,	the	solvent	was	evaporated	and	aqueous	NaOH	(5	mL,	1	M)	
was	added.	The	mixture	was	extracted	with	CH2Cl2	(2	×	5	mL).	
The	 combined	 extracts	were	 dried	 (MgSO4),	 evaporated,	 and	
purified	 by	 column	 chromatography	 on	 silica,	 eluting	 with	
CH2Cl2–MeOH	(97:3),	to	give	the	amine	13	(50	mg,	87%)	as	an	
oil;	Rf	0.34	[CH2Cl2–MeOH	(9:1)];	
1
H	NMR		(400	MHz,	CDCl3)	δ	=	
6.71	 (1H,	 s,	CH),	6.59	 (1H,	 s,	CH),	3.86	 (6H,	 s,	2	 x	CH3),	 3.20–
2.96	(4H,	m,	4	x	CH),	2.66–2.50	(2H,	m,	2	x	CH),	2.38–2.27	(2H,	
m,	2	x	CH),	1.97–1.92	(1H,	m,	CH),	1.76–1.70	(2H,	m,	2	x	CH),	
1.56–1.42	(2H,	m,	2	x	CH);	
13
C	NMR	(100	MHz,	CDCl3)	δ=	147.3,	
147.1,	130.2,	126.6,	111.4,	108.1,	63.2,	56.9,	56.0,	55.8,	52.8,	
31.5,	 29.0,	 25.4,	 25.0;	 HRMS	 (ES)	 Found:	 MH
+
,	 248.1655.	
C15H21NO2	requires	MH
+	
248.1645;	Data	as	reported.
10	
	
tert-Butyl	 1-[3-(2-tert-Butoxycarbonyl-6,7-dimethoxy-1,2,3,4-	
tetrahydroisoquinolin-1-yl)propyl]-6,7-dimethoxy-1,2,3,4-
tetrahydroisoquinoline-2-carboxylate	14	
n-BuLi	 (3.2	 mL,	 8.2	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	2	(2.0	g,	6.8	mmol)	in	THF	(28	mL)	at	–
50	 °C.	After	4	min,	Br(CH2)3Br	 (0.3	mL,	3.4	mmol)	was	added.	
The	mixture	was	allowed	to	warm	to	 room	temperature	over	
16	h	and	MeOH	(1	mL)	was	added.	The	solvent	was	evaporated	
and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (99:1),	 to	 give	 the	
carbamate	 14	 (2.8	 g,	 64%)	 as	 a	 separable	 mixture	 of	
diastereomers	(dr	1:1),	each	as	an	oil:	
Isomer	 A:	 Rf	 0.27	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	
2970,	2935,	1685,	1520;	
1
H	NMR		(400	MHz,	CDCl3,	rotamers)	δ	
=	6.63–6.55	(4H,	m,	4	x	CH),	5.12–5.10	(1H,	m,	CH),	4.98–4.96	
(1H,	m,	 CH),	 4.22–4.19	 (0.85H,	m,	 CH),	 3.97–3.92	 (1.15H,	m,	
CH),	3.85	(12H,	br	s,	4	x	CH3),	3.27–3.15	(2H,	m,	CH),	2.86–2.81	
(2H,	m,	CH),	2.63–2.59	(2H,	m,	CH),	1.93–1.72	(4H,	m,	2	x	CH),	
1.63–1.53	 (2H,	 m,	 CH),	 1.47	 (18H,	 br	 s,	 t-Bu);	
13
C	 NMR	 (100	
MHz,	CDCl3,	rotamers)	δ=	155.0	&	154.9,	147.6,	147.3,	130.6	&	
130.1,	 126.4	 &	 126.0,	 111.6	 &	 111.4,	 110.3	 &	 110.0,	 79.7	 &	
79.2,	 56.1,	 55.9,	 54.7	&	53.4,	 38.4	&	38.2,	 36.9	&	36.2,	 28.5,	
28.1	&	27.9,	23.5	&	23.2;	HRMS	(ES)	Found:	MNa
+
,	649.3456.	
C19H25NO4Na	 requires	 MNa
+	
649.3433;	 LRMS	 m/z	 (ES)	 649	
(100%).	
Isomer	 B:	 Rf	 0.28	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	
2970,	2935,	1685,	1520;	
1
H	NMR		(400	MHz,	CDCl3,	rotamers)	δ	
=	6.63–6.55	(4H,	m,	4	x	CH),	5.12–5.10	(1H,	m,	CH),	4.98–4.96	
(1H,	m,	CH),	4.22–4.19	(0.8H,	m,	CH),	4.03–3.94	(1.2H,	m,	CH),	
3.85	(12H,	br	s,	4	x	CH3),	3.27–3.15	(2H,	m,	CH),	2.86–2.81	(2H,	
m,	CH),	2.63–2.59	(2H,	m,	CH),	1.93–1.72	(4H,	m,	2	x	CH),	1.63–
1.53	 (2H,	m,	 CH),	 1.47	 (18H,	 br	 s,	 t-Bu);	
13
C	 NMR	 (100	MHz,	
CDCl3,	 rotamers)	 δ=	 155.0	 &	 154.8,	 147.5,	 147.3,	 130.5	 &	
130.0,	 126.3	 &	 125.8,	 111.6	 &	 111.4,	 110.3	 &	 109.9,	 79.7	 &	
79.2,	 56.1,	 56.0,	 54.6	&	53.5,	 38.3	&	38.0,	 36.9	&	35.5,	 28.5,	
28.1	&	27.9,	23.6	&	23.2;	HRMS	(ES)	Found:	MNa
+
,	649.3456.	
C19H25NO4Na	 requires	 MNa
+	
649.3433;	 LRMS	 m/z	 (ES)	 649	
(100%).	
	
tert-Butyl	 6,7-Dimethoxy-1-(prop-2-yn-1-yl)-1,2,3,4-
tetrahydroisoquinoline-2-carboxylate	15	
n-BuLi	 (1.63	mL,	 4.08	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	2	(1.0	g,	3.4	mmol)	in	THF	(14	mL)	at	–
50	°C.	After	4	min,	propargyl	bromide	(0.36	mL,	4.1	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
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column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	15	(0.88	g,	78%)	as	an	oil;	
Rf	 0.1	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	 2970,	 2930,	
1690,	1520,	1415;	
1
H	NMR	(400	MHz,	CDCl3,	rotamers)	δ	=	6.78	
(1H,	 s,	 CH),	 6.61	 (1H,	 s,	 CH),	 5.27–5.24	 (0.5H,	 m,	 CH),	 5.14	
(0.5H,	t,	J	6,	CH),	4.21–4.18	(0.5H,	m,	CH),	3.97–3.93	(0.5H,	m,	
CH),	3.87	 (6H,	 s,	2	x	CH3),	3.47–3.42	 (0.5H,	m,	CH),	3.31–3.26	
(0.5H,	 m,	 CH),	 2.87–2.71	 (4H,	 m,	 4	 x	 CH),	 2.02–2.00	 (1H,	 m,	
CH),	 1.50	 (9H,	 s,	 t-Bu);	
13
C	 NMR	 (100	MHz,	 CDCl3,	 rotamers,	
alkyne	 C	 atoms	 could	 not	 be	 observed)	 δ	 =	 154.6	 &	 154.4,	
147.9	&	147.8,	147.3,	127.8	&	127.6,	126.7	&	126.5,	111.4	&	
111.2,	 110.5	&	110.1,	 80.1	&	79.8,	 55.9	&	55.8,	 53.1	&	52.4,	
39.1	&	37.3,	28.4,	28.3	&	28.0,	26.5	&	26.1;	HRMS	(ES)	Found:	
MNa
+
,	354.1668.	C19H25NO4Na	requires	MNa
+	
354.1681;	LRMS	
m/z	(ES)	354	(100%).	
	
tert-Butyl	 6,7-Dimethoxy-1-[(4-methoxyphenyl)methyl]-
1,2,3,4-tetrahydroisoquinoline-2-carboxylate	16	
n-BuLi	 (1.6	 mL,	 4.1	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	2	(1.0	g,	3.4	mmol)	in	THF	(14	mL)	at	–
50	 °C.	 After	 4	 min,	 4-methoxybenzyl	 chloride	 (0.6	 mL,	 4.1	
mmol)	was	added.	The	mixture	was	allowed	to	warm	to	room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(92:8),	to	give	the	carbamate	16	(980	mg,	70%)	as	an	oil;	
Rf	 0.11	 [petrol–EtOAc	 (90:10)];	 νmax	 (neat)/cm
–1
	 3005,	 2990,	
1675,	 1510,	 1415;	
1
H	 NMR	 	 (400	MHz,	 CDCl3,	 rotamers)	 δ	 =	
7.05–7.02	 (2H,	 m,	 2	 x	 CH),	 6.85–6.80	 (2H,	 m,	 2	 x	 CH),	 6.63	
(0.67H,	 s,	 CH),	 6.60	 (0.33H,	 s,	 CH),	 6.34	 (0.67H,	 s,	 CH),	 6.20	
(0.33H,	s,	CH),	5.22	(0.33H,	t,	J	7,	CH),	5.07	(0.67H,	t,	J	7,	CH),	
4.15	(0.67H,	ddd,	J	12,	5,	3,	CH),	3.87	(3H,	s,	OCH3),	3.85–3.77	
(0.33H,	m,	CH),	3.80	(3H,	s,	OCH3),	3.75	(2H,	s,	OCH3),	3.65	(1H,	
s,	OCH3),	3.37–3.22	(1H,	m,	CH),	3.10–3.00	(1H,	m,	CH),	2.96–
2.72	(2H,	m,		2	x	CH),	2.65–2.55	(1H,	m,	CH),	1.45	(3H,	s,	t-Bu),	
1.35	 (6H,	 s,	 	 t-Bu);	
13
C	 NMR	 (100	MHz,	 CDCl3,	 rotamers)	 δ	 =	
158.3	&	158.1,	154.6	&	154.5,	147.6	&	147.5,	146.9	&	146.7,	
130.8	&	130.6,	130.7	&	130.5,	128.8	&	128.6,	126.6	&	126.3,	
113.7	 &	 113.5,	 111.3	 &	 111.0,	 110.7	 &	 110.3,	 79.5	 &	 79.4,	
56.5,	55.9	&	55.8,	55.7	&	55.6,	55.3	&	55.2,	42.0	&	41.8,	39.3	&	
37.2,	 28.5	 &	 28.3,	 28.2;	 HRMS	 (ES)	 Found:	 MNa
+
,	 436.2103.	
C24H31NO5Na	 requires	 MNa
+
	 436.2100;	 LRMS	 m/z	 (ES)	 436	
(100%),	
	
tert-Butyl	 1-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-6,7-
dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carboxylate	17	
The	 tetrahydroisoquinoline	 15	 (500	 mg,	 1.5	 mmol),	 benzyl	
azide	 (200	 mg,	 1.8	 mmol),	 CuSO4·H2O	 (300	 mg,	 1.8	 mmol),	
ascorbic	 acid	 (300	 mg,	 1.8	 mmol),	 L-proline	 (200	 mg,	 1.81	
mmol),	and	Na2CO3	 (100	mg,	1.8	mmol)	were	heated	at	65	°C	
in	 DMSO–water	 (10	 mL,	 9:1).	 After	 18	 h,	 the	 mixture	 was	
cooled	to	room	temperature	and	saturated	aqueous	NH4Cl	(30	
mL)	was	added.	The	precipitate	was	filtered	and	washed	with	
water	 (100	mL).	 The	 combined	 extracts	 were	 dried	 (MgSO4),	
evaporated,	and	purified	by	column	chromatography	on	silica	
gel,	 eluting	with	petrol–EtOAc	 (60:40),	 to	 give	 the	 carbamate	
17	(570	mg,	83%)	as	an	oil;	Rf	0.11	[petrol–EtOAc	(50:50)];	νmax	
(neat)/cm
–1
	3000,	2970,	1690,	1365;	
1
H	NMR		(400	MHz,	CDCl3,	
rotamers)	δ	=	7.35–7.15	(6H,	m,	6	x	CH),	6.66–6.56	(2H,	m,	2	x	
CH),	5.55–5.36	(3H,	m,	3	x	CH),	4.28–4.21	(0.5H,	m,	CH),	3.98–
3.91	 (0.5H,	 m,	 CH),	 3.85	 (3H,	 s,	 OCH3),	 3.81	 (1.7H,	 s,	 OCH3),	
3.76	 (1.3H,	 s,	OCH3),	 3.21–3.02	 (2.5H,	m,	 CH),	 3.02–2.76	 (1H,	
m,	CH),	 2.62–2.57	 (1H,	m,	CH),	 1.99–1.84	 (0.5H,	m,	CH),	 1.38	
(3H,	 s,	 t-Bu),	 1.26	 (6H,	 s,	 t-Bu);	
13
C	 NMR	 (100	 MHz,	 CDCl3,	
rotamers)	 δ	 =	 154.8	 &	 154.4,	 147.8,	 147.4,	 145.2	 &	 144.8,	
135.0	 &	 134.6,	 129.1,	 128.8,	 128.7	 &	 128.6,	 128.0	 &	 127.9,	
126.2,	121.9,	111.4,	109.9,	79.7	&	79.5,	56.0	&	55.9,	54.4,	54.0,	
53.1,	 38.3	&	36.4,	 32.8,	 28.3	&	28.1,	 28.0;	HRMS	 (ES)	 Found:	
MNa
+
,	487.2316.	C26H32N4O4Na	requires	MNa
+	
487.2325;	LRMS	
m/z	(ES)	487	(100%).	
	
5-Benzyl-6-methyl-2H,5H,6H,7H,8H-[1,3]-dioxolo[4,5-
g]isoquinoline	18	
The	 carbamate	 6b	 (100	 mg,	 0.24	 mmol)	 in	 THF	 (1	 mL)	 was	
added	to	a	suspension	of	LiAlH4	(500	mg,	1.2	mmol)	in	THF	(5	
mL)	 at	 0	 °C	 under	 nitrogen.	 The	mixture	was	 stirred	 at	 room	
temperature	for	1	h	then	was	heated	under	reflux.	After	16	h,	
the	 mixture	 was	 allowed	 to	 cool	 to	 room	 temperature.	
Aqueous	 NaOH	 (5	mL,	 1	M)	 was	 added	 dropwise.	 The	 solids	
were	 removed	 by	 filtration	 though	 Celite	 and	 were	 washed	
with	 CH2Cl2–MeOH	 (9:1).	 The	 filtrate	 was	 evaporated	 and	
purified	 by	 column	 chromatography	 on	 silica,	 eluting	 with	
CH2Cl2–MeOH	(95:5),	to	give	the	amine	18	(50	mg,	69%)	as	an	
oil;	 Rf	 0.4	 [CH2Cl2–MeOH	 (9.5:0.5)];	 νmax	 (neat)/cm
–1
	 2925,	
2775,	1480;	
1
H	NMR	(250	MHz,	CDCl3)	δ	=	7.30–7.26	(2H,	m,	2	
x	CH),	7.23–7.19	 (1H,	m,	CH),	7.16–7.14	 (2H,	m,	2	x	CH),	6.56	
(1H,	s,	CH),	6.22	(1H,	s,	CH),	5.91–5.87	(2H,	m,	CH),	3.74	(1H,	t,	
J	6,	CH),	3.24–3.11	(2H,	m,	2	x	CH),	2.90–2.73	(3H,	m,	3	x	CH),	
2.59–2.53	 (1H,	m,	CH),	 2.49	 (3H,	 s,	 CH3);	
13
C	NMR	 (100	MHz,	
CDCl3)	 δ=	 145.8,	 145.3,	 139.9,	 130.6,	 129.5,	 128.1,	 127.2,	
126.0,	108.4,	107.8,	100.5,	65.2,	46.6,	42.6,	41.6,	25.7;	HRMS	
(ES)	Found:	MH
+
,	282.1491.	C18H20NO2	requires	MH
+
	282.1494,	
LRMS	m/z	(ES)	282	(100%).	
	
tert-Butyl	 1-[2-(2H-1,3-Benzodioxol-5-yl)ethyl]-6,7-
dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carboxylate	20	
n-BuLi	 (1.63	mL,	 4.08	mmol,	 2.5	M	 in	 hexane)	was	 added	 to	
tetrahydroisoquinoline	2	(1.0	g,	3.4	mmol)	in	THF	(14	mL)	at	–
50	°C.	After	4	min,	bromide	19	(900	mg,	1.6	mmol)	was	added.	
The	mixture	was	allowed	to	warm	to	 room	temperature	over	
16	h	and	MeOH	(1	mL)	was	added.	The	solvent	was	evaporated	
and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (92:8),	 to	 give	 the	
carbamate	 20	 (1.08	 g,	 72%)	 as	 an	 oil;	 Rf	 0.12	 [petrol–EtOAc	
(80:20)];	 νmax	 (neat)/cm
–1
	 2970,	 2930,	 1685,	 1515;	
1
H	 NMR		
(400	MHz,	CDCl3,	rotamers)	δ	=	6.75–6.58	(5H,	m,	5	x	CH),	5.93	
(2H,	 s,	 OCH2O),	 5.18–5.01	 (1H,	 m,	 CH),	 4.28–4.26	 (0.5H,	 m,	
CH),	4.05–4.00	 (0.5H,	m,	CH),	3.86	 (6H,	 s,	2	x	CH3),	3.29–3.17	
(1H,	m,	CH),	2.98–2.59	(4H,	m,	3	x	CH),	2.10–2.00	(2H,	m,	2	x	
CH),	1.50	(9H,	s,	t-Bu);	
13
C	NMR	(100	MHz,	CDCl3,	rotamers)	δ	=	
154.9,	147.7,	147.4,	145.6,	136.0	&	135.7,	130.1,	129.6,	126.3	
&	 125.9,	 120.9,	 111.6,	 110.2	 &	 109.9,	 108.7	 &	 108.1,	 100.7,	
79.9	&	79.4,	56.0	&	55.9,	54.4	&	53.6,	39.1	&	38.7,	36.9,	32.7,	
28.5,	 28.1	 &	 27.9;	 HRMS	 (ES)	 Found:	 MNa
+
,	 464.2032	
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C25H31NO6Na	 requires	 MNa
+
	 464.2049,	 LRMS	 m/z	 (ES)	 464	
(100%).	
	
Dysoxyline	21	
In	the	same	way	as	the	amine	18,	the	carbamate	20	(100	mg,	
0.24	 mmol)	 and	 LiAlH4	 (500	 mg,	 1.2	 mmol)	 gave,	 after	
purification	by	column	chromatography	on	silica,	eluting	with	
Et2O–petrol	(97.5:2.5),	(±)-dysoxyline	21	(60	mg,	75%)	as	an	oil;	
Rf	 0.12	 [Petrol–Et2OH	 (90:10)];	 νmax	 (neat)/cm
–1
	 2935,	 2780,	
1515,	1490;	
1
H	NMR		 (400	MHz,	CDCl3)	δ	=	6.74–6.69	(2H,	m,	
CH),	6.66–6.62	 (1H,	m,	CH),	6.58	 (1H,	s,	CH),	6.55	 (1H,	s,	CH),	
5.92	(2H,	s,	OCH2O),	3.85	(3H,	s,	OCH3),	3.82	(3H,	s,	OCH3),	3.42	
(1H,	 t,	 J	5,	CH),	 3.20–3.12	 (1H,	m,	CH),	 2.82–2.63	 (4H,	m,	4	 x	
CH),	2.54–2.46	(1H,	m,	CH),	2.48	(3H,	s,	NCH3),	2.05–2.00	(2H,	
m,	2	x	CH);	
13
C	NMR	(100	MHz,	CDCl3)	δ	=	147.5,	147.3,	147.2,	
145.4,	 136.8,	 129.7,	 126.7,	 121.0,	 111.2,	 110.0,	 108.9,	 108.1,	
100.7,	62.6,	56.0,	55.8,	48.2,	42.7,	37.1,	31.3,	25.4;	HRMS	(ES)	
Found:	 MH
+
,	 356.1859.	 C21H26NO4	 requires	 MH
+	
356.1862.	
Data	as	reported.
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